Health
Hormone-resistant prostate, breast cancers added to clinical trial of experimental DNA therapy – News-Medical.Net
The Republic of Belarus Ministry of Health has approved expanding the ongoing clinical trial of CureLab Oncology’s Elenagen,…
The Republic of Belarus Ministry of Health has approved expanding the ongoing clinical trial of CureLab Oncology’s Elenagen™, an experimental DNA therapy, to include two new arms: 1) hormone-resistant breast cancer; and 2) hormone-resistant metastatic prostate…
Continue Reading
-
Business20 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News20 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News21 hours agoYoung voices shape Sunshine Coast’s future
-
Noosa News18 hours agoSudden death investigation, Maroochydore – Sunshine Coast